{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:51:50Z","timestamp":1758635510626},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T00:00:00Z","timestamp":1178755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Largely due to the lack of diagnostic reagents, the prevalence and clinical presentation of cryptococcal meningitis in Tanzania is poorly understood. This in turn is limiting the impact of increased fluconazole availability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We evaluated a cohort of 149 consecutive HIV-infected adult inpatients presenting with headache or altered mental status for clinical features, CD4 count, cryptococcal infection, and outcome. Cryptococcal meningitis was diagnosed via India ink and latex agglutination assay of CSF (<jats:italic>n<\/jats:italic> = 24 and 40 positive, respectively). Associations between cryptococcal meningitis and clinical features were evaluated by t-test. The sensitivity, specificity, and positive likelihood ratio of such features were determined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Cryptococcal meningitis was associated with confusion, social withdrawal, seizures, fever, tachycardia, meningismus, oral candidiasis, and low Glasgow coma scales and CD4 count. CD4 count &lt; 100\/\u03bcl provided the highest sensitivity for the diagnosis (93%), coma (Glasgow coma scale \u2264 8) provided the highest specificity (84%), and the combination provided the highest positive likelihood ratio (3.8). All cryptococcal meningitis patients were initiated on 800 milligrams of fluconazole daily and 50% survived to discharge, however no clinical or laboratory findings correlated with prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Cryptococcal meningitis is common among Tanzanian HIV inpatients presenting with headache or altered mental status. Purely clinical features are insensitive for establishing the diagnosis or prognosis. We advocate expanding laboratory capacity for cryptococcal antigen testing to maximize survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-7-39","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T18:13:36Z","timestamp":1178820816000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania"],"prefix":"10.1186","volume":"7","author":[{"given":"Peter R","family":"Kisenge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander T","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venance P","family":"Maro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John PD","family":"Mchele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndealilia S","family":"Swai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R","family":"Houpt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,10]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/pmj.77.914.769","volume":"77","author":"P Mwaba","year":"2001","unstructured":"Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S, Zumla A: Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J. 2001, 77: 769-773. 10.1136\/pmj.77.914.769.","journal-title":"Postgrad Med J"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","volume":"14","author":"JG Hakim","year":"2000","unstructured":"Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, Robertson VJ, Musvaire P, Mason PR: Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. Aids. 2000, 14: 1401-1407. 10.1097\/00002030-200007070-00013.","journal-title":"Aids"},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1086\/339540","volume":"34","author":"EL Corbett","year":"2002","unstructured":"Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, Clayton TC, Grant AD, Murray J, Hayes RJ, De Cock KM: Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis. 2002, 34: 1251-1258. 10.1086\/339540.","journal-title":"Clin Infect Dis"},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijid.2005.07.004","volume":"10","author":"C Bekondi","year":"2006","unstructured":"Bekondi C, Bernede C, Passone N, Minssart P, Kamalo C, Mbolidi D, Germani Y: Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis. 2006, 10: 387-395. 10.1016\/j.ijid.2005.07.004.","journal-title":"Int J Infect Dis"},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/516298","volume":"26","author":"RS Heyderman","year":"1998","unstructured":"Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, Musvaire P, Robertson VJ, Mason PR: Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis. 1998, 26: 284-289.","journal-title":"Clin Infect Dis"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4314\/eamj.v78i9.8974","volume":"78","author":"MI Matee","year":"2001","unstructured":"Matee MI, Matre R: Pathogenic isolates in meningitis patients in Dar Es Salaam, Tanzania. East Afr Med J. 2001, 78: 458-460.","journal-title":"East Afr Med J"},{"key":"482_CR7","unstructured":"Price Catalogue of Essential Medicines and Hospital Supplies. 2007, Dar es Salaam, Tanzania"},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"72; author repl","DOI":"10.1016\/S0140-6736(03)12124-1","volume":"361","author":"K Sebati","year":"2003","unstructured":"Sebati K: Pfizer Diflucan Partnership Program. Lancet. 2003, 361: 72; author reply 72-10.1016\/S0140-6736(03)12124-1.","journal-title":"Lancet"},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, Harrison TS: Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004, 363: 1764-1767. 10.1016\/S0140-6736(04)16301-0.","journal-title":"Lancet"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ije\/27.4.698","volume":"27","author":"M Okongo","year":"1998","unstructured":"Okongo M, Morgan D, Mayanja B, Ross A, Whitworth J: Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol. 1998, 27: 698-702. 10.1093\/ije\/27.4.698.","journal-title":"Int J Epidemiol"},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","volume":"353","author":"X Anglaret","year":"1999","unstructured":"Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N'Dri-Yoman T, Salamon R: Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet. 1999, 353: 1463-1468. 10.1016\/S0140-6736(98)07399-1.","journal-title":"Lancet"},{"key":"482_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/clinids\/22.5.838","volume":"22","author":"F Menichetti","year":"1996","unstructured":"Menichetti F, Fiorio M, Tosti A, Gatti G, Bruna Pasticci M, Miletich F, Marroni M, Bassetti D, Pauluzzi S: High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1996, 22: 838-840.","journal-title":"Clin Infect Dis"},{"key":"482_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0163-4453(94)94161-0","volume":"28","author":"D Maher","year":"1994","unstructured":"Maher D, Mwandumba H: Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. J Infect. 1994, 28: 59-64. 10.1016\/S0163-4453(94)94161-0.","journal-title":"J Infect"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","volume":"16","author":"N French","year":"2002","unstructured":"French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo D, Whitworth JA, Gilks CF: Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002, 16: 1031-1038. 10.1097\/00002030-200205030-00009.","journal-title":"AIDS"},{"key":"482_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/516372","volume":"26","author":"H Mayanja-Kizza","year":"1998","unstructured":"Mayanja-Kizza H, Oishi K, Mitarai S, Yamashita H, Nalongo K, Watanabe K, Izumi T, Ococi J, Augustine K, Mugerwa R, Nagatake T, Matsumoto K: Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis. 1998, 26: 1362-1366.","journal-title":"Clin Infect Dis"},{"key":"482_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/clinids\/23.4.827","volume":"23","author":"M Feldmesser","year":"1996","unstructured":"Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A: Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis. 1996, 23: 827-830.","journal-title":"Clin Infect Dis"},{"key":"482_CR17","unstructured":"World Health Report. 2006, Geneva, World Health Organization"},{"key":"482_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","volume":"80","author":"RD Diamond","year":"1974","unstructured":"Diamond RD, Bennett JE: Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974, 80: 176-181.","journal-title":"Ann Intern Med"},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJM199503163321102","volume":"332","author":"WG Powderly","year":"1995","unstructured":"Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, et al: A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995, 332: 700-705. 10.1056\/NEJM199503163321102.","journal-title":"N Engl J Med"},{"key":"482_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG: Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998, 17: 873-890. 10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I.","journal-title":"Stat Med"},{"key":"482_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","volume":"44","author":"DL Simel","year":"1991","unstructured":"Simel DL, Samsa GP, Matchar DB: Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991, 44: 763-770. 10.1016\/0895-4356(91)90128-V.","journal-title":"J Clin Epidemiol"},{"key":"482_CR22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/bmj.324.7341.824","volume":"324","author":"J Steurer","year":"2002","unstructured":"Steurer J, Fischer JE, Bachmann LM, Koller M, ter Riet G: Communicating accuracy of tests to general practitioners: a controlled study. Bmj. 2002, 324: 824-826. 10.1136\/bmj.324.7341.824.","journal-title":"Bmj"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:29:43Z","timestamp":1630499383000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-39","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,10]]},"assertion":[{"value":"6 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}